Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (NCT07815418) titled 'The Relationship Between Novel Virological Indicators and Treatment With Different Nucleotide Analogues and the Prognosis of HBV-ACLF Patients' on Sept. 7.

Study Type: Observational

Primary Sponsor: Tongji Hospital

Condition: Acute-on-Chronic Liver Failure (ACLF) hepatitisB Treatment

Recruitment Status: Not recruiting

Date of First Enrollment: February 1, 2022

Target Sample Size: 235

Countries of Recruitment: China

To know more, visit https://clinicaltrials.gov/study/NCT07815418

Published by HT Digital Content Services with permission from Health Daily Digest....